116 related articles for article (PubMed ID: 7735480)
1. Measurement of 5,10-dideaza-5,6,7,8-tetrahydrofolate (lometrexol) in human plasma and urine by high-performance liquid chromatography.
Wedge SR; Laohavinij S; Taylor GA; Newell DR
J Chromatogr B Biomed Appl; 1995 Jan; 663(2):327-35. PubMed ID: 7735480
[TBL] [Abstract][Full Text] [Related]
2. Specific and sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of lometrexol and its polyglutamates in biologic samples.
Muindi JR; Young CW; Shih C
J Chromatogr; 1993 Nov; 621(1):55-64. PubMed ID: 7508451
[TBL] [Abstract][Full Text] [Related]
3. Simple and sensitive method for the quantitative analysis of lometrexol in plasma using high-performance liquid chromatography with electrochemical detection.
Synold TW; Xi B; Newman EM; Muggia FM; Doroshow JH
J Chromatogr B Biomed Appl; 1996 Aug; 683(2):245-9. PubMed ID: 8891922
[TBL] [Abstract][Full Text] [Related]
4. Bioanalysis of the investigational anti-tumour drug 5,10-dideaza-5,6,7,8-tetrahydrofolic acid by high-performance liquid chromatography with ultraviolet detection.
van Tellingen O; Sips JH; Beijnen JH; Schornagel JH; Nooyen WJ
J Chromatogr; 1992 Apr; 576(1):158-62. PubMed ID: 1500451
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement.
Wedge SR; Laohavinij S; Taylor GA; Boddy A; Calvert AH; Newell DR
Clin Cancer Res; 1995 Dec; 1(12):1479-86. PubMed ID: 9815947
[TBL] [Abstract][Full Text] [Related]
6. Competitive particle concentration fluorescence immunoassay for measuring 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (lometrexol) in serum.
Taber LD; O'Brien P; Bowsher RR; Sportsman JR
Clin Chem; 1991 Feb; 37(2):254-60. PubMed ID: 1993335
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive coupled-column high-performance liquid chromatographic method for the separation and quantitation of the diastereomers of leucovorin and 5-methyltetrahydrofolate in serum and urine.
Schleyer E; Reinhardt J; Unterhalt M; Hiddemann W
J Chromatogr B Biomed Appl; 1995 Jul; 669(2):319-30. PubMed ID: 7581908
[TBL] [Abstract][Full Text] [Related]
8. Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation.
Roberts JD; Poplin EA; Tombes MB; Kyle B; Spicer DV; Grant S; Synold T; Moran R
Cancer Chemother Pharmacol; 2000; 45(2):103-10. PubMed ID: 10663624
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of a new anticancer agent (NB-506) and its active metabolite in human plasma and urine by high-performance liquid chromatography with ultraviolet detection.
Takenaga N; Ishii Y; Monden S; Sasaki Y; Hata S
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):111-7. PubMed ID: 8749258
[TBL] [Abstract][Full Text] [Related]
10. Determination of 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in rat, dog and human plasma and urine by high-performance liquid chromatography with fluorescence detection.
Hanson GD; Slattum P; Tidwell RR; Bekersky I; Mong S
J Chromatogr; 1993 Dec; 622(1):61-9. PubMed ID: 8120114
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2- [2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino]propi onylamino ) butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84,364) in dog and human plasma by high-performance liquid chromatography.
Allen MC; Stafford CG; Nocerini MR
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):243-51. PubMed ID: 9323544
[TBL] [Abstract][Full Text] [Related]
12. Assay of tocainide enantiomers in plasma by solid-phase extraction and indirect chiral high-performance liquid chromatography after derivatization with (-)-menthyl chloroformate.
Christensen EB; Hansen SH; Rasmussen SN
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):243-9. PubMed ID: 8548014
[TBL] [Abstract][Full Text] [Related]
13. Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urine.
Schellens JH; Loos W; Beijnen JH; Stoter G; Verweij J
J Chromatogr; 1993 Jun; 615(2):309-15. PubMed ID: 8335709
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography.
Rivory LP; Clarke SJ; Boyer M; Bishop JF
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(2):135-40. PubMed ID: 11767306
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatographic determination of sotalol in plasma and urine employing solid-phase extraction and fluorescence detection.
Bartek MJ; Vekshteyn M; Boarman MP; Gallo DG
J Chromatogr; 1987 Oct; 421(2):309-18. PubMed ID: 3429585
[TBL] [Abstract][Full Text] [Related]
16. Determination of minocycline in human plasma by high-performance liquid chromatography with UV detection after liquid-liquid extraction.
Mascher HJ
J Chromatogr A; 1998 Jul; 812(1-2):339-42. PubMed ID: 9691330
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.
Andersen A; Warren DJ; Brunsvig PF; Aamdal S; Kristensen GB; Olsen H
BMC Clin Pharmacol; 2006 Jan; 6():2. PubMed ID: 16412237
[TBL] [Abstract][Full Text] [Related]
18. Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine.
Kurata N; Kuramitsu T; Tanii H; Fuse E; Kuwabara T; Kobayashi H; Kobayashi S
J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):223-7. PubMed ID: 9653966
[TBL] [Abstract][Full Text] [Related]
19. Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography.
Muth P; Metz R; Siems B; Bolten WW; Vergin H
J Chromatogr A; 1996 Apr; 729(1-2):251-8. PubMed ID: 9004947
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.
Bullen WW; Whitfield LR; Walter GA; Brodfuehrer JI
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):141-51. PubMed ID: 7550971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
